Patent ID: 7989585
Filing Date: 2011-08-02
Classification: A61K,A61P,C07K

Abstract:
1. A method of treating hyperglycemia and type 2 diabetes which comprises maintaining chronic steady state plasma levels between about 60 picomoles/liter and about 200 picomoles/liter of Arg 34 Lys 26 -(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1(7-37) in biologically active form wherein Arg 34 Lys 26 -(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1(7-37) is administered by subcutaneous injection to a human subject no more than once or twice every 24 hours.